Top Markets
Coin of the day
Evolutionary Genomics, Inc. Evolutionary Genomics, Inc.

Evolutionary Genomics, Inc.

FNAM
Rank in Stocks #42444
Evolutionary Genomics, Inc., together with its subsidiaries, engages in the... Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. The company is based in Castle Rock, Colorado.
Share Price
$0.0002
Last synced: 2026-08-11
Market Cap
$1.33K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Evolutionary Genomics, Inc. (FNAM)

Category

Operating Margin for Evolutionary Genomics, Inc. (FNAM)
Operating Margin as of 2026 TTM: 0.00%
According to Evolutionary Genomics, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Evolutionary Genomics, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.97% -
US
28.81% -
NL
0.00% -
CH
31.23% -
BE
0.00% -
KR
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.